JOSEPH THOMAS RUBINO
Pharmacy in Towaco, NJ

License number
Pennsylvania RP029647L
Category
Pharmacy
Type
Pharmacist
Address
Address 2
Towaco, NJ 07082
Pennsylvania

Personal information

See more information about JOSEPH THOMAS RUBINO at radaris.com
Name
Address
Phone
Joseph Rubino
57 Street Rd, Newtown Sq, PA 19073
(610) 564-1614
Joseph Rubino, age 61
609A Shaler Blvd, Ridgefield, NJ 07657
(201) 953-1460
Joseph Rubino, age 69
50 Cedar Hill Ave, Belleville, NJ 07109
(973) 951-7227
Joseph Rubino
61 Sprague St, Wilmerding, PA 15148
(412) 559-0497
Joseph Rubino, age 89
67 9Th St, Wyoming, PA 18644
(570) 498-3064

Professional information

Joseph Rubino Photo 1

Calicheamicin Derivative-Carrier Conjugates

US Patent:
2004019, Sep 30, 2004
Filed:
Nov 3, 2003
Appl. No.:
10/699874
Inventors:
Arthur Kunz - New City NY, US
Justin Moran - Valley Cottage NY, US
Joseph Rubino - Towaco NJ, US
Neera Jain - New City NY, US
Eugene Vidunas - Middletown NY, US
John Simpson - Upper Nyack NY, US
Nishith Merchant - Palisades Park NJ, US
John DiJoseph - Woodbridge NJ, US
Mark Ruppen - Garnerville NY, US
Nitin Damle - Upper Saddle River NJ, US
Paul Robbins - Derwood MD, US
Andrew Popplewell - Staines, GB
Assignee:
Wyeth Holdings Corporation - Madison NJ
International Classification:
C07K016/46, C07K014/47
US Classification:
530/391100, 530/403000, 530/409000
Abstract:
Methods for preparing monomeric cytotoxic drug/carrier conjugates with a drug loading significantly higher than in previously reported procedures and with decreased aggregation and low conjugate fraction (LCF) are described. Cytotoxic drug derivative/antibody conjugates, compositions comprising the conjugates and uses of the conjugates are also described. Monomeric calicheamicin derivative/anti-CD22 antibody conjugates, compositions comprising the conjugates and uses of the conjugates are also described.


Joseph Rubino Photo 2

Calicheamicin Derivative-Carrier Conjugates

US Patent:
8153768, Apr 10, 2012
Filed:
May 2, 2003
Appl. No.:
10/428894
Inventors:
Arthur Kunz - New City NY, US
Justin Keith Moran - Valley Cottage NY, US
Joseph Thomas Rubino - Towaco NJ, US
Neera Jain - New City NY, US
Eugene Joseph Vidunas - Middletown NY, US
John McLean Simpson - Upper Nyack NY, US
Paul David Robbins - Upper Nyack NY, US
Nishith Merchant - Palisades Park NJ, US
John Francis DiJoseph - Woodbridge NJ, US
Mark Edward Ruppen - Garnerville NY, US
Nitin Krishnaji Damle - Upper Saddle River NJ, US
Andrew George Popplewell - Staines, GB
Assignee:
Wyeth Holdings Corporation - Madison NJ
International Classification:
C07K 16/00, C07K 17/00, C07K 16/28
US Classification:
5303911, 5303917, 5303919, 530409
Abstract:
Methods for preparing monomeric cytotoxic drug/carrier conjugates with a drug loading significantly higher than in previously reported procedures and with decreased aggregation and low conjugate fraction (LCF) are described. Cytotoxic drug derivative/antibody conjugates, compositions comprising the conjugates and uses of the conjugates are also described. Monomeric calicheamicin derivative/anti-CD22 antibody conjugates, compositions comprising the conjugates and uses of the conjugates are also described.


Joseph Rubino Photo 3

Parenteral Cci-779 Formulations Containing Cosolvents, An Antioxidant, And A Surfactant

US Patent:
8026276, Sep 27, 2011
Filed:
Jul 25, 2003
Appl. No.:
10/626943
Inventors:
Joseph T. Rubino - Towaco NJ, US
Victoria Siskavich - Lyon Mountain NY, US
Maureen M. Harrison - Sugar Loaf NY, US
Pooja Gandhi - Highland Mills NY, US
Assignee:
Wyeth LLC - Madison NJ
International Classification:
A61K 31/435
US Classification:
514450, 514454, 514338, 514294, 514885, 514970
Abstract:
Parenteral formulations of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl) -2-methylpropionic acid (CCI-779) are provided. One parenteral formulation contains CCI-779, an alcoholic co-solvent, and an antioxidant. Another parenteral formulation contains CCI-779, an alcoholic solvent, an antioxidant, a diluent solvent, and a surfactant. Processes for preparing parenteral CCI-779 formulations using a co-solvent concentrate are also provided.


Joseph Rubino Photo 4

Calicheamicin Conjugates

US Patent:
2009010, Apr 23, 2009
Filed:
Aug 4, 2008
Appl. No.:
12/221551
Inventors:
Arthur Kunz - New City NY, US
Justin Keith Moran - Valley Cottage NY, US
Joseph Thomas Rubino - Towaco NJ, US
Neera Jain - Lexington MA, US
Erwin Raymond Arsene Boghaert - Monroe NY, US
Philip Ross Hamann - Thiells NY, US
Mark Edward Ruppen - Garnerville NY, US
Nitin Krishnaji Damle - Upper Saddle River NJ, US
Eugene Vidunas - Middletown NY, US
Lyka Kalyandrug - Congers NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
C07K 16/00
US Classification:
5303919
Abstract:
Anti-Lewis Y antibodies are described. Methods for preparing monomeric cytotoxic drug/carrier conjugates with a drug loading significantly higher than in previously reported procedures and with decreased aggregation and low conjugate fraction (LCF) are described. Cytotoxic drug derivative/antibody conjugates, compositions comprising the conjugates and uses of the conjugates are also described. Specifically, monomeric calicheamicin derivative/anti-Lewis Y antibody conjugates, compositions comprising the conjugates and uses of the conjugates are also described.


Joseph Rubino Photo 5

Control Of Cci-779 Dosage Form Stability Through Control Of Drug Substance Impurities

US Patent:
2007014, Jun 21, 2007
Filed:
Dec 19, 2006
Appl. No.:
11/642029
Inventors:
Joseph Rubino - Towaco NJ, US
Pooja Gandhi - Highland Mills NY, US
Lynn Phelan - Lake Hiawatha NJ, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/4745, A61K 31/355, A61K 31/375
US Classification:
514291000, 514458000, 514474000
Abstract:
A method of preparing a rapamycin composition having increased potency is provided. The method involves selecting a rapamycin compound having less than 1.5% oxidative and hydrolytic rapamycin impurities and formulating the selected rapamycin with an antioxidant and optional excipients.


Joseph Rubino Photo 6

Calicheamicin Conjugates

US Patent:
2006000, Jan 5, 2006
Filed:
Mar 15, 2005
Appl. No.:
11/080587
Inventors:
Arthur Kunz - New City NY, US
Justin Moran - Valley Cottage NY, US
Joseph Rubino - Towaco NJ, US
Neera Jain - Monroe NY, US
Erwin Raymond Boghaert - Monroe NY, US
Philip Hamann - Thiells NY, US
Mark Ruppen - Garnerville NY, US
Nitin Damle - Upper Saddle River NJ, US
Eugene Vidunas - Middletown NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 39/395, C07K 16/46
US Classification:
424178100, 530391100
Abstract:
Anti-Lewis Y antibodies are described. Methods for preparing monomeric cytotoxic drug/carrier conjugates with a drug loading significantly higher than in previously reported procedures and with decreased aggregation and low conjugate fraction (LCF) are described. Cytotoxic drug derivative/antibody conjugates, compositions comprising the conjugates and uses of the conjugates are also described. Specifically, monomeric calicheamicin derivative/anti-Lewis Y antibody conjugates, compositions comprising the conjugates and uses of the conjugates are also described.


Joseph Rubino Photo 7

Cci-779 Concentrate Formulations

US Patent:
8299116, Oct 30, 2012
Filed:
Aug 10, 2011
Appl. No.:
13/206641
Inventors:
Joseph T Rubino - Towaco NJ, US
Victoria Siskavich - Lyon Mountain NY, US
Maureen M Harrison - Sugar Loaf NY, US
Pooja Gandhi - Highland Mills NY, US
Assignee:
Wyeth LLC - Madison NJ
International Classification:
A61K 31/435
US Classification:
514450, 514454, 514338, 514294, 514885, 514970
Abstract:
This invention provides CCI-779 cosolvent concentrates which are useful in preparing a parenteral formulation of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) following admixture with a diluent.


Joseph Rubino Photo 8

Cci-779 Lyophilized Formulations

US Patent:
2005002, Jan 27, 2005
Filed:
Jul 19, 2004
Appl. No.:
10/894210
Inventors:
Joseph Rubino - Towaco NJ, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K031/4745
US Classification:
514291000
Abstract:
Lyophilized CCI-779 formulations composed of CCI-779 and t-butyl alcohol or ethanol are described. Also provided are solutions useful in preparing said lyophilized CCI-779 formulations, methods of reconstituting same, and uses for same.